DREAMM 13
Showing 1 - 25 of 2,839
Multiple Myeloma Trial in Greece, Korea, Republic of, United States (Belantamab mafodotin)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
-
Tucson, Arizona
- +21 more
Jul 20, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +150 more
Dec 9, 2022
Multiple Myeloma, Refractory Trial in Washington, Hackensack, Neptune (Pembrolizumab, Belantamab mafodotin, Dexamethasone)
Not yet recruiting
- Multiple Myeloma, Refractory
- Pembrolizumab
- +2 more
-
Washington, District of Columbia
- +2 more
Aug 5, 2022
Relapsed/Refractory Multiple Myeloma Trial in United States (Belantamab mafodotin)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- Belantamab mafodotin
-
Clayton, North Carolina
- +4 more
May 16, 2023
Opioid Prescribing Trial in Ann Arbor (Academic detailing)
Not yet recruiting
- Opioid Prescribing
- Academic detailing
-
Ann Arbor, MichiganUniversity of Michigan
Nov 8, 2023
Plasma Von Willebrand Factor Antigen to A Disintegrin-like and
Not yet recruiting
- Acute on Chronic Liver Failure
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences.
Sep 28, 2023
Ulcerative Colitis Trial in Ukraine, United States (NX-13 250mg IR, NX-13 500mg IR, NX-13 500mg MR)
Completed
- Ulcerative Colitis
- NX-13 250mg IR
- +3 more
-
Huntsville, Alabama
- +30 more
Jan 6, 2023
Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance
Recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 3, 2022
HIV, Hypertension Trial in Kampala (Integrated HIV/HTN care model)
Active, not recruiting
- HIV
- Hypertension
- Integrated HIV/HTN care model
-
Kampala, Central Region, UgandaInfectious Diseases Research Collaboration
Nov 1, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +34 more
Jul 22, 2022
Aging Trial (vaccine)
Not yet recruiting
- Aging
- vaccine
- (no location specified)
Nov 8, 2023
Primary Brain Tumor Trial in Houston (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Spectroscopic Imaging)
Recruiting
- Primary Brain Neoplasm
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Alzheimer Dementia
- CpG1018
- Placebo
- (no location specified)
Jan 3, 2023
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Poitiers (Isatuximab, Carfilzomib, Pomalidomide)
Active, not recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- Isatuximab
- +3 more
-
Poitiers, FranceCHU Poitiers
Jan 9, 2023
Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C
Active, not recruiting
- Prostate Adenocarcinoma
- +9 more
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Healthy Trial in Kaunas (Low-load and high-velocity - lying prone - eccentric hamstring exercise)
Completed
- Healthy
- Low-load and high-velocity - lying prone - eccentric hamstring exercise
-
Kaunas, LithuaniaLithuanian Sports University
Sep 26, 2023
Patients Experiences of Early Postoperative Cognition
Completed
- Postoperative Cognitive Decline
- +3 more
- Cognitive decline
-
Stockholm, SwedenUlrica Nilsson
Jan 23, 2023
Pneumoccocal Immunisation Trial in United States (Pneumococcal Conjugate Vaccine - formulation 1, Pneumococcal Conjugate Vaccine
Completed
- Pneumoccocal Immunisation
- Pneumococcal Conjugate Vaccine - formulation 1
- +4 more
-
Anaheim, California
- +16 more
Aug 1, 2022
Adult Gliomas, Mixed Trial in San Francisco (Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG), Magnetic Resonance Image
Recruiting
- Adult Gliomas, Mixed
- Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
- Magnetic Resonance Image (MRI)
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 9, 2023
Ovarian Cancer Trial in Houston (Hyperpolarized 13-C-pyruvate)
Not yet recruiting
- Ovarian Cancer
- Hyperpolarized 13-C-pyruvate
-
Houston, TexasM D Anderson Cancer Center
May 10, 2023
Chronic Pain, Pain, Pediatric ALL Trial in Vilanova i la Geltrú (Pain Science Education)
Active, not recruiting
- Chronic Pain
- +2 more
- Pain Science Education
-
Vilanova i la Geltrú, Barcelona, SpainLaura Menés Fernández
Sep 23, 2023
Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™)
Completed
- Pneumococcal Infections
- V114
- Prevnar 13™
-
Downey, California
- +75 more
Sep 22, 2022
Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)
Completed
- Epidermolysis Bullosa
- Serlopitant Tablet
- Placebo Oral Tablet
-
Redwood City, CaliforniaStanford University
Nov 30, 2022
Well-Being, Psychological, Child, Only Trial in Dublin (A Lust for Life, Waiting List Control)
Recruiting
- Well-Being, Psychological
- Child, Only
- A Lust for Life
- Waiting List Control
-
Dublin, Leinster, IrelandUniversity College Dublin
Nov 13, 2023
Cervical Cancer, Endometrial Cancer Trial (Hypofractionated Image guided External Beam Radiation Therapy (EBRT), Cisplatin,
Not yet recruiting
- Cervical Cancer
- Endometrial Cancer
- Hypofractionated Image guided External Beam Radiation Therapy (EBRT)
- +2 more
- (no location specified)
May 11, 2023